Home > News > Profiting From His Inner Geek
November 2nd, 2007
Profiting From His Inner Geek
At least that's the hope, but others are not as sanguine. Jurvetson has been an especially visible booster of nanotechnology, the science of fabricating new products at the atomic and molecular levels. Among other things, he has spoken on panels, gone to Washington to lobby for research funds, and talked up the field's potential in the press. His company has also invested approximately $100 million in 30 nanotech-related companies. But so far, nanotech remains an area with potential only, with no hugely profitable nanotechnology firms having been started yet.
"To me, he has become Mr. Nanotech," says Lawrence Aragon, editor in chief of Venture Capital Journal, a trade publication, of Jurvetson. "If there's a big winner in there, he will be totally validated. But that's the trick with V.C. You can be right about a technology, and your timing could be completely wrong."
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Premier Healthcare Pitch Competition comes to Atlanta this May April 12th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014